U.S. Home Hemodialysis Market, By Type (Conventional, Short Daily Hemodialysis, Nocturnal Hemodialysis), Product (Device, Consumables, Service), Treatment (Acute Kidney Disease, Chronic Kidney Disease), Distribution Channel (Direct Tenders, Third Party Distribution) – Industry Trends and Forecast to 2031.
U.S. Home Hemodialysis Market Analysis and Size
According to the World Health Organization (WHO), the global prevalence of Chronic Kidney Disesae (CKD) is estimated to be around 13.4%, with higher rates in populations with diabetes, hypertension, and cardiovascular disease, In the United States, the incidence rate of ESRD was approximately 357 cases per million population in 2018, according to the United States Renal Data System (USRDS). Also, the American Cancer Society estimates that in 2022, there will be about 76,080 new cases of kidney cancer (46,240 in men and 29,840 in women).
Data Bridge Market Research analyses that the U.S. home hemodialysis market which was USD 9.85 million in 2023, will reach to USD 22.21 million by 2031, and is expected to undergo a CAGR of 10.7% during the forecast period. “Short daily hemodialysis” dominates the type segment of the home hemodialysis market owing to the growing demand for better methods for treatment in patients. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, and Pricing in USD
|
|
Segments Covered
|
Type (Conventional, Short Daily Hemodialysis, Nocturnal Hemodialysis), Product (Device, Consumables, Service), Treatment (Acute Kidney Disease, Chronic Kidney Disease), Distribution Channel (Direct Tenders, Third Party Distribution)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
Baxter (U.S.), B Braun Melsungen AG (Germany), Fresenius Medical Care AG (Germany), Medtronic (Ireland), Asahi Kasei Medical Co., Ltd., (Japan), Nipro Corp (Japan), DaVita (U.S.), Becton, Dickinson and Company (U.S.), Nikkiso Co., Ltd. (Japan), Cantel Medical (U.S.), among others
|
|
Market Opportunities
|
|
Market Definition
Home hemodialysis is a form of renal replacement therapy where individuals with kidney failure perform hemodialysis treatments in the comfort of their own home. It allows patients to have more flexibility in their treatment schedules and often leads to improved quality of life compared to in-center hemodialysis.
U.S. Home Hemodialysis Market Dynamics
Drivers
- Patient Preference and Quality of Life
Many patients with end-stage renal disease (ESRD) prefer home hemodialysis over in-center hemodialysis due to the flexibility it offers. Performing treatments at home allows patients to schedule dialysis sessions according to their convenience, which can significantly improve their quality of life. Home hemodialysis also reduces the need for frequent travel to dialysis centers, saving time and transportation costs. Additionally, patients may experience fewer dietary and fluid restrictions with more frequent home hemodialysis, leading to better overall health outcomes. As patient-centric care becomes increasingly emphasized in healthcare, the demand for home hemodialysis is likely to continue growing.
- Advancements in Technology and Remote Monitoring
Technological advancements in home hemodialysis machines and remote monitoring systems have made it safer and more convenient for patients to perform treatments at home. Modern home hemodialysis machines are user-friendly, compact, and equipped with features that ensure treatment accuracy and safety. Remote monitoring systems allow healthcare providers to monitor patients' vital signs, treatment adherence, and machine performance remotely, enabling timely intervention in case of any issues. These technological advancements not only improve patient outcomes but also provide peace of mind to both patients and healthcare providers, contributing to the expansion of the home hemodialysis market.
Opportunities
- Expansion of Patient Access to Renal Replacement Therapy
Home hemodialysis presents an opportunity to expand access to renal replacement therapy (RRT) for patients with end-stage renal disease (ESRD), especially in regions or communities where access to in-center dialysis facilities is limited. This is particularly relevant in rural or underserved areas where patients may face challenges accessing healthcare services due to geographical barriers or lack of transportation infrastructure. By offering home hemodialysis as an alternative to in-center treatment, healthcare providers can improve access to RRT for a broader patient population, ultimately enhancing patient outcomes and reducing healthcare disparities.
- Integration of Telehealth and Remote Monitoring Solution
The integration of telehealth and remote monitoring solutions presents an opportunity to enhance the delivery of home hemodialysis services and improve patient outcomes. Telehealth platforms enable healthcare providers to remotely monitor patients' vital signs, treatment adherence, and clinical parameters in real-time, facilitating early detection of complications and timely intervention. In addition, telehealth consultations allow patients to communicate with their healthcare providers, receive education and support, and access medical advice without the need for in-person visits.
Restraints/Challenges
- Reimbursement and Financial Barriers
One restraint to the widespread adoption of home hemodialysis is the complex reimbursement landscape and financial barriers. While home hemodialysis offers potential cost savings compared to in-center dialysis, reimbursement policies and coverage limitations vary between healthcare systems and payers. In some regions, reimbursement rates for home hemodialysis may not adequately cover the costs associated with training, equipment, supplies, and ongoing support services, making it financially challenging for both patients and healthcare providers to transition to home-based dialysis care. Additionally, patients may face out-of-pocket expenses for copayments, deductibles, and ancillary costs related to home hemodialysis, which can act as a barrier to adoption, particularly for those with limited financial resources.
- Patient Education and Training
One challenge in the home hemodialysis market is ensuring comprehensive patient education and training to empower patients to perform dialysis safely and effectively at home. Home hemodialysis requires patients to acquire new skills, such as operating dialysis machines, managing vascular access, monitoring vital signs, and recognizing signs of complications. Effective patient education and training programs are essential to ensure that patients feel confident and competent in managing their dialysis treatments independently at home. However, providing comprehensive education and training can be resource-intensive for healthcare providers, requiring dedicated staff, time, and infrastructure to deliver personalized, hands-on instruction and ongoing support to patients and their caregivers. Moreover, factors such as language barriers, health literacy, and cognitive impairment may further complicate the education and training process, underscoring the need for tailored approaches to meet the diverse needs of patients undergoing home hemodialysis.
This Home Hemodialysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Home Hemodialysis market contact Data Bridge Market Research for an analyst brief, our team will help you make an informed market decision to achieve market growth.
Recent Developments
- In 2021, Mar Cor (Cantel Medical Corporation) announced the launch of its innovative EON Portable hemodialysis Water System
- In 2020, Baxter International Inc. received FDA approval for De Novo application for Theranova dilayzers designed to deliver expanded hemodialysis (HDx) therapy
U.S. Home Hemodialysis Market Scope
The home hemodialysis market is segmented on the basis of type, product, treatment, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Conventional
- Short Daily Hemodialysis
- Nocturnal Hemodialysis
Product
- Device
- Machine
- Dialyzers
- Water Treatment System
- Others
- Consumables
- Bloodlines
- Concentrates
- Catheters
- Others
- Service
Treatment
- Acute Kidney Disease
- Chronic Kidney Disease
Distribution Channel
- Direct Tenders
- Third Party Distribution
U.S. Home Hemodialysis Market Regional Analysis/Insights
The U.S. home hemodialysis market is analysed and market size insights and trends are provided by country, type, product, treatment, and distribution channel as referenced above.
The countries covered in the home hemodialysis market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and rest of Middle East and Africa.
North America dominates the home hemodialysis market because of the strong base of healthcare facilities, highest geriatric population and youth suffering from chronic diseases like diabetes and blood pressure.
Asia-Pacific is expected to witness significant growth during the forecast period of 2024 to 2031 due to the government initiatives, increasing healthcare spending, rising awareness campaigns regarding CKD, technologically enhanced products, and the presence of newly-established state-of-the-art healthcare facilities in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of U.S. brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The home hemodialysis market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the home hemodialysis market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the home hemodialysis market.
Competitive Landscape and Home Hemodialysis Market Share Analysis
The home hemodialysis market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, country presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the home hemodialysis market are:
- Baxter (U.S.)
- B Braun Melsungen AG (Germany)
- Fresenius Medical Care AG (Germany)
- Medtronic (Ireland)
- Asahi Kasei Medical Co., Ltd., (Japan)
- Nipro Corp (Japan)
- DaVita (U.S.)
- Becton, Dickinson and Company (U.S.)
- Nikkiso Co., Ltd. (Japan)
- Cantel Medical (U.S.)
SKU-